{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Bardet-Biedl Syndrome",
      "relation": "contraindication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_acetazolamide",
          "type": "Drug",
          "label": "Acetazolamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_furosemide",
          "type": "Drug",
          "label": "Furosemide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_sodium_valproate",
          "type": "Drug",
          "label": "Sodium Valproate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_thiazide_diuretics",
          "type": "Drug",
          "label": "Thiazide diuretics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ibuprofen",
          "type": "Drug",
          "label": "Ibuprofen",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_atenolol",
          "type": "Drug",
          "label": "Atenolol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_metoprolol",
          "type": "Drug",
          "label": "Metoprolol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_topiramate",
          "type": "Drug",
          "label": "Topiramate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_digoxin",
          "type": "Drug",
          "label": "Digoxin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_phenytoin",
          "type": "Drug",
          "label": "Phenytoin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_lithium",
          "type": "Drug",
          "label": "Lithium",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_bardet_biedl_syndrome",
          "type": "Disease",
          "label": "Bardet-Biedl Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_diuretic",
          "type": "Pathway",
          "label": "Diuretic Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_neurotransmitter",
          "type": "Pathway",
          "label": "Neurotransmitter Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Acetazolamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_acetazolamide",
          "type": "Drug",
          "label": "Acetazolamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Furosemide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_furosemide",
          "type": "Drug",
          "label": "Furosemide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Sodium Valproate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_sodium_valproate",
          "type": "Drug",
          "label": "Sodium Valproate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Thiazide diuretics",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_thiazide_diuretics",
          "type": "Drug",
          "label": "Thiazide diuretics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Ibuprofen",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_ibuprofen",
          "type": "Drug",
          "label": "Ibuprofen",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Atenolol",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_atenolol",
          "type": "Drug",
          "label": "Atenolol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Metoprolol",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_metoprolol",
          "type": "Drug",
          "label": "Metoprolol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Topiramate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_topiramate",
          "type": "Drug",
          "label": "Topiramate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Digoxin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_digoxin",
          "type": "Drug",
          "label": "Digoxin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Phenytoin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_phenytoin",
          "type": "Drug",
          "label": "Phenytoin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Lithium",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_lithium",
          "type": "Drug",
          "label": "Lithium",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "n_acetazolamide",
          "target": "n_pathway_diuretic",
          "relation": "modulates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "药理上与排尿功能相关"
        },
        {
          "source": "n_furosemide",
          "target": "n_pathway_diuretic",
          "relation": "modulates",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "排尿作用明确相关联"
        },
        {
          "source": "n_sodium_valproate",
          "target": "n_pathway_neurotransmitter",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "与神经递质通路的调节一致"
        },
        {
          "source": "n_thiazide_diuretics",
          "target": "n_pathway_diuretic",
          "relation": "modulates",
          "weight": 0.88,
          "agent": "Proponent",
          "rationale": "已知利尿机制说明"
        },
        {
          "source": "n_ibuprofen",
          "target": "n_pathway_neurotransmitter",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "涉及痛觉与炎症反应的通路"
        },
        {
          "source": "n_atenolol",
          "target": "n_pathway_neurotransmitter",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "β-adrenergic 作用相关"
        },
        {
          "source": "n_metoprolol",
          "target": "n_pathway_neurotransmitter",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "影响心脏功能与神经调节相关"
        },
        {
          "source": "n_beta_blockers",
          "target": "n_pathway_neurotransmitter",
          "relation": "modulates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "β受体的调节作用推导"
        },
        {
          "source": "n_topiramate",
          "target": "n_pathway_neurotransmitter",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "与抑制性神经递质相关"
        },
        {
          "source": "n_digoxin",
          "target": "n_pathway_neurotransmitter",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "促进心脏功能相关通路"
        },
        {
          "source": "n_phenytoin",
          "target": "n_pathway_neurotransmitter",
          "relation": "modulates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "与神经传递通路调节一致"
        },
        {
          "source": "n_lithium",
          "target": "n_pathway_neurotransmitter",
          "relation": "modulates",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "机制与神经调节相关"
        },
        {
          "source": "n_pathway_diuretic",
          "target": "n_bardet_biedl_syndrome",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知与病理机制关联"
        },
        {
          "source": "n_pathway_neurotransmitter",
          "target": "n_bardet_biedl_syndrome",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "神经机制可能影响病症"
        },
        {
          "source": "n_acetazolamide",
          "target": "H1",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "通过利尿机制影响Bardet-Biedl综合征"
        },
        {
          "source": "n_furosemide",
          "target": "H2",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "支持与利尿相关的作用"
        },
        {
          "source": "n_sodium_valproate",
          "target": "H3",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通过神经调节相关机制"
        },
        {
          "source": "n_thiazide_diuretics",
          "target": "H4",
          "relation": "supports",
          "weight": 0.88,
          "agent": "Proponent",
          "rationale": "确立了病理机制的关联"
        },
        {
          "source": "n_ibuprofen",
          "target": "H5",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "具备相关机制支持"
        },
        {
          "source": "n_atenolol",
          "target": "H6",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可能影响心脏功能相关机制"
        },
        {
          "source": "n_metoprolol",
          "target": "H7",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "对心脏与神经传递的影响"
        },
        {
          "source": "n_beta_blockers",
          "target": "H8",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "对β受体影响的推论"
        },
        {
          "source": "n_topiramate",
          "target": "H9",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "与神经抑制机制的支持"
        },
        {
          "source": "n_digoxin",
          "target": "H10",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "通过心血管机制的影响"
        },
        {
          "source": "n_phenytoin",
          "target": "H11",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "神经递质影响的潜力"
        },
        {
          "source": "n_lithium",
          "target": "H12",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "可能对神经调节的影响"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.62,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.85,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "通过利尿机制影响Bardet-Biedl综合征的证据支持"
            ],
            "safety_risk": [
              "未发现明显的禁忌相关证据"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H2",
          "score": 0.66,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.7,
            "safety_risk": 0.2,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.9,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "排尿作用明确相关联，支持Bardet-Biedl综合征的管理"
            ],
            "safety_risk": [
              "未发现明显的禁忌相关证据"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H3",
          "score": 0.57,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.5,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "通过神经调节相关机制与Bardet-Biedl综合征相关"
            ],
            "safety_risk": [
              "未发现明显的禁忌相关证据"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H4",
          "score": 0.64,
          "components": {
            "mechanism_fit": 0.85,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.65,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.88,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "确立了病理机制的关联，支持与Bardet-Biedl综合征的治疗"
            ],
            "safety_risk": [
              "未发现明显的禁忌相关证据"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H5",
          "score": 0.53,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.5,
            "safety_risk": 0.25,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "具备相关机制支持Bardet-Biedl综合征的治疗"
            ],
            "safety_risk": [
              "可能存在安全性问题，但具体证据不足"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H6",
          "score": 0.55,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.55,
            "safety_risk": 0.15,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "可能影响心脏功能相关机制，但与Bardet-Biedl综合征的直接联系不强"
            ],
            "safety_risk": [
              "未发现明显的禁忌相关证据"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H7",
          "score": 0.54,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.55,
            "safety_risk": 0.15,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "影响心脏功能与神经调节相关，但与Bardet-Biedl综合征的直接关联不明确"
            ],
            "safety_risk": [
              "未发现明显的禁忌相关证据"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H8",
          "score": 0.53,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.55,
            "safety_risk": 0.15,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "对β受体影响的推论，可能与Bardet-Biedl综合征的管理相关"
            ],
            "safety_risk": [
              "未发现明显的禁忌相关证据"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H9",
          "score": 0.56,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.55,
            "safety_risk": 0.15,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "与抑制性神经递质相关，可能影响Bardet-Biedl综合征"
            ],
            "safety_risk": [
              "未发现明显的禁忌相关证据"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H10",
          "score": 0.52,
          "components": {
            "mechanism_fit": 0.55,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.5,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.55,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "通过心血管机制的影响，但与Bardet-Biedl综合征的直接关联不明显"
            ],
            "safety_risk": [
              "未发现明显的禁忌相关证据"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H11",
          "score": 0.48,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "神经递质影响的潜力，但与疾病的直接联系不强"
            ],
            "safety_risk": [
              "未发现明显的禁忌相关证据"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H12",
          "score": 0.45,
          "components": {
            "mechanism_fit": 0.45,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.45,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "可能对神经调节有影响，但具体证据不足"
            ],
            "safety_risk": [
              "存在一定的安全性风险，需考虑"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "可能的禁忌机制",
            "expectation": "若存在禁忌，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Acetazolamide 在 Bardet-Biedl 综合征患者中可能的安全性和禁忌症",
          "对治疗效果的长期评估"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "可能的禁忌机制",
            "expectation": "若存在禁忌，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Furosemide 在 Bardet-Biedl 综合征患者中的适用性"
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "可能的禁忌机制",
            "expectation": "若存在禁忌，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Sodium Valproate 的使用与 Bardet-Biedl 综合征的关系"
        ]
      },
      {
        "hypothesis_id": "H4",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "可能的禁忌机制",
            "expectation": "若存在禁忌，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Thiazide diuretics 在 Bardet-Biedl 综合征患者中的安全性"
        ]
      },
      {
        "hypothesis_id": "H5",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "可能的禁忌机制",
            "expectation": "若存在禁忌，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Ibuprofen 对 Bardet-Biedl 综合征的潜在风险"
        ]
      },
      {
        "hypothesis_id": "H6",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "可能的禁忌机制",
            "expectation": "若存在禁忌，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Atenolol 的使用与 Bardet-Biedl 综合征的关系"
        ]
      },
      {
        "hypothesis_id": "H7",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "可能的禁忌机制",
            "expectation": "若存在禁忌，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Metoprolol 可能在 Bardet-Biedl 综合征中的影响"
        ]
      },
      {
        "hypothesis_id": "H8",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "可能的禁忌机制",
            "expectation": "若存在禁忌，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Beta-blockers 的使用在 Bardet-Biedl 综合征中的安全性"
        ]
      },
      {
        "hypothesis_id": "H9",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "可能的禁忌机制",
            "expectation": "若存在禁忌，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Topiramate 针对 Bardet-Biedl 综合征的治疗谨慎性"
        ]
      },
      {
        "hypothesis_id": "H10",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "可能的禁忌机制",
            "expectation": "若存在禁忌，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Digoxin 的使用与 Bardet-Biedl 综合征的潜在禁忌"
        ]
      },
      {
        "hypothesis_id": "H11",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "可能的禁忌机制",
            "expectation": "若存在禁忌，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Phenytoin 在 Bardet-Biedl 综合征中的适用性分析"
        ]
      },
      {
        "hypothesis_id": "H12",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "可能的禁忌机制",
            "expectation": "若存在禁忌，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Lithium 的潜在风险评估与 Bardet-Biedl 综合征的关系"
        ]
      }
    ]
  }
}